APAS is an artificial intelligence technology that automates the imaging, analysis, interpretation and reporting of microbiology culture plates after incubation, according to a news release. The system allows for a faster diagnosis of infectious diseases.
“We believe APAS technology is going to make a significant difference to the efficiency of microbiology laboratories globally,” said Peter Bradley, general manger of Zurich-based Clever Culture Systems.
Clever Culture Systems will launch APAS in 2017.
More articles on supply chain:
Alnylam halts drug’s development after patient deaths in study
4 latest FDA approvals
Dana-Farber, Brigham and Women’s in ‘urgent need’ of platelet donations
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
